Publisher's Synopsis
Reflects current rules, regulations, and guidelines in Title 21 of the Code of Federal Regulations and presents the latest advances in expediting drug development procedures.;The book is designed to be of interest to research and development personnel in the pharmaceutical industry, including clinical and research pharmacists and pharmacologists, organic, medicinal, cosmetic, analytical, and clinical chemists and biochemists, clinical toxicologists, biostatisticians, government regulatory personnel, international pharmaceutical manufacturers and students in drug development courses.
